Literature DB >> 33726819

Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method.

Prashant Nasa1, Elie Azoulay2, Ashish K Khanna3, Ravi Jain4, Sachin Gupta5, Yash Javeri6, Deven Juneja7, Pradeep Rangappa8, Krishnaswamy Sundararajan9, Waleed Alhazzani10, Massimo Antonelli11, Yaseen M Arabi12, Jan Bakker13,14,15, Laurent J Brochard16, Adam M Deane17, Bin Du18, Sharon Einav19, Andrés Esteban20, Ognjen Gajic21, Samuel M Galvagno22, Claude Guérin23,24, Samir Jaber25,26, Gopi C Khilnani27, Younsuck Koh28, Jean-Baptiste Lascarrou29, Flavia R Machado30, Manu L N G Malbrain31,32, Jordi Mancebo33, Michael T McCurdy34, Brendan A McGrath35,36, Sangeeta Mehta37, Armand Mekontso-Dessap38, Mervyn Mer39, Michael Nurok40, Pauline K Park41, Paolo Pelosi42,43, John V Peter44, Jason Phua45, David V Pilcher46, Lise Piquilloud47, Peter Schellongowski48, Marcus J Schultz49,50,51, Manu Shankar-Hari52,53, Suveer Singh54, Massimiliano Sorbello55, Ravindranath Tiruvoipati56, Andrew A Udy57, Tobias Welte58, Sheila N Myatra59.   

Abstract

BACKGROUND: Coronavirus disease 2019 (COVID-19) pandemic has caused unprecedented pressure on healthcare system globally. Lack of high-quality evidence on the respiratory management of COVID-19-related acute respiratory failure (C-ARF) has resulted in wide variation in clinical practice.
METHODS: Using a Delphi process, an international panel of 39 experts developed clinical practice statements on the respiratory management of C-ARF in areas where evidence is absent or limited. Agreement was defined as achieved when > 70% experts voted for a given option on the Likert scale statement or > 80% voted for a particular option in multiple-choice questions. Stability was assessed between the two concluding rounds for each statement, using the non-parametric Chi-square (χ2) test (p < 0·05 was considered as unstable).
RESULTS: Agreement was achieved for 27 (73%) management strategies which were then used to develop expert clinical practice statements. Experts agreed that COVID-19-related acute respiratory distress syndrome (ARDS) is clinically similar to other forms of ARDS. The Delphi process yielded strong suggestions for use of systemic corticosteroids for critical COVID-19; awake self-proning to improve oxygenation and high flow nasal oxygen to potentially reduce tracheal intubation; non-invasive ventilation for patients with mixed hypoxemic-hypercapnic respiratory failure; tracheal intubation for poor mentation, hemodynamic instability or severe hypoxemia; closed suction systems; lung protective ventilation; prone ventilation (for 16-24 h per day) to improve oxygenation; neuromuscular blocking agents for patient-ventilator dyssynchrony; avoiding delay in extubation for the risk of reintubation; and similar timing of tracheostomy as in non-COVID-19 patients. There was no agreement on positive end expiratory pressure titration or the choice of personal protective equipment.
CONCLUSION: Using a Delphi method, an agreement among experts was reached for 27 statements from which 20 expert clinical practice statements were derived on the respiratory management of C-ARF, addressing important decisions for patient management in areas where evidence is either absent or limited. TRIAL REGISTRATION: The study was registered with Clinical trials.gov Identifier: NCT04534569.

Entities:  

Keywords:  COVID 19 invasive mechanical ventilation; COVID-19 acute respiratory distress syndrome; COVID-19 high flow nasal oxygen; COVID-19 respiratory management; COVID-19 ventilatory management; Respiratory distress syndrome adult

Year:  2021        PMID: 33726819      PMCID: PMC7962430          DOI: 10.1186/s13054-021-03491-y

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


  69 in total

1.  Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies.

Authors:  R A Armstrong; A D Kane; T M Cook
Journal:  Anaesthesia       Date:  2020-07-15       Impact factor: 6.955

2.  Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response.

Authors:  Giacomo Grasselli; Antonio Pesenti; Maurizio Cecconi
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

Review 3.  COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?

Authors:  Eddy Fan; Jeremy R Beitler; Laurent Brochard; Carolyn S Calfee; Niall D Ferguson; Arthur S Slutsky; Daniel Brodie
Journal:  Lancet Respir Med       Date:  2020-07-06       Impact factor: 30.700

4.  The baby lung and the COVID-19 era.

Authors:  Luciano Gattinoni; Konrad Meissner; John J Marini
Journal:  Intensive Care Med       Date:  2020-05-25       Impact factor: 17.440

5.  Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.

Authors:  Annemarie B Docherty; Ewen M Harrison; Christopher A Green; Hayley E Hardwick; Riinu Pius; Lisa Norman; Karl A Holden; Jonathan M Read; Frank Dondelinger; Gail Carson; Laura Merson; James Lee; Daniel Plotkin; Louise Sigfrid; Sophie Halpin; Clare Jackson; Carrol Gamble; Peter W Horby; Jonathan S Nguyen-Van-Tam; Antonia Ho; Clark D Russell; Jake Dunning; Peter Jm Openshaw; J Kenneth Baillie; Malcolm G Semple
Journal:  BMJ       Date:  2020-05-22

6.  P-SILI is not justification for intubation of COVID-19 patients.

Authors:  Martin J Tobin; Franco Laghi; Amal Jubran
Journal:  Ann Intensive Care       Date:  2020-08-03       Impact factor: 6.925

Review 7.  Caution about early intubation and mechanical ventilation in COVID-19.

Authors:  Martin J Tobin; Franco Laghi; Amal Jubran
Journal:  Ann Intensive Care       Date:  2020-06-09       Impact factor: 6.925

8.  COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome.

Authors:  Luciano Gattinoni; Silvia Coppola; Massimo Cressoni; Mattia Busana; Sandra Rossi; Davide Chiumello
Journal:  Am J Respir Crit Care Med       Date:  2020-05-15       Impact factor: 21.405

9.  COVID-19 pneumonia: different respiratory treatments for different phenotypes?

Authors:  Luciano Gattinoni; Davide Chiumello; Pietro Caironi; Mattia Busana; Federica Romitti; Luca Brazzi; Luigi Camporota
Journal:  Intensive Care Med       Date:  2020-04-14       Impact factor: 17.440

10.  International variation in the management of severe COVID-19 patients.

Authors:  Elie Azoulay; Jan de Waele; Ricard Ferrer; Thomas Staudinger; Marta Borkowska; Pedro Povoa; Katerina Iliopoulou; Antonio Artigas; Stefan J Schaller; Manu Shankar-Hari; Mariangela Pellegrini; Michael Darmon; Jozef Kesecioglu; Maurizio Cecconi
Journal:  Crit Care       Date:  2020-08-05       Impact factor: 9.097

View more
  29 in total

Review 1.  Early spontaneous breathing for acute respiratory distress syndrome in individuals with COVID-19.

Authors:  Friedrich Hohmann; Lisa Wedekind; Felicitas Grundeis; Steffen Dickel; Johannes Frank; Martin Golinski; Mirko Griesel; Clemens Grimm; Cindy Herchenhahn; Andre Kramer; Maria-Inti Metzendorf; Onnen Moerer; Nancy Olbrich; Volker Thieme; Astrid Vieler; Falk Fichtner; Jacob Burns; Sven Laudi
Journal:  Cochrane Database Syst Rev       Date:  2022-06-29

2.  The use of video laryngoscopy outside the operating room: A systematic review.

Authors:  Emma J Perkins; Jonathan L Begley; Fiona M Brewster; Nathan D Hanegbi; Arun A Ilancheran; David J Brewster
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

3.  Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial.

Authors:  Stephan Ehrmann; Jie Li; Miguel Ibarra-Estrada; Yonatan Perez; Ivan Pavlov; Bairbre McNicholas; Oriol Roca; Sara Mirza; David Vines; Roxana Garcia-Salcido; Guadalupe Aguirre-Avalos; Matthew W Trump; Mai-Anh Nay; Jean Dellamonica; Saad Nseir; Idrees Mogri; David Cosgrave; Dev Jayaraman; Joan R Masclans; John G Laffey; Elsa Tavernier
Journal:  Lancet Respir Med       Date:  2021-08-20       Impact factor: 30.700

4.  Case Report: Respiratory Management With a 47-Day ECMO Support for a Critical Patient With COVID-19.

Authors:  Wen Xu; Ruoming Tan; Jie Huang; Shuai Qin; Jing Wu; Yuzhen Qiu; Simin Xie; Yan Xu; Ying Du; Feng Li; Bailing Li; Yingchuan Li; Yuan Gao; Xin Li; Hongping Qu
Journal:  Front Med (Lausanne)       Date:  2021-12-24

Review 5.  Protective ventilation in patients with acute respiratory distress syndrome related to COVID-19: always, sometimes or never?

Authors:  Chiara Mega; Irene Cavalli; Vito Marco Ranieri; Tommaso Tonetti
Journal:  Curr Opin Crit Care       Date:  2022-02-01       Impact factor: 3.687

6.  COVID-19-related ARDS: one disease, two trajectories, and several unanswered questions.

Authors:  Jean-Baptiste Lascarrou
Journal:  Lancet Respir Med       Date:  2021-10-13       Impact factor: 30.700

7.  Intubation to Nowhere in COVID-19: Can Noninvasive Ventilation Help?

Authors:  Philippe R Bauer
Journal:  Mayo Clin Proc       Date:  2021-11-12       Impact factor: 11.104

Review 8.  Noninvasive respiratory support and patient self-inflicted lung injury in COVID-19: a narrative review.

Authors:  Denise Battaglini; Chiara Robba; Lorenzo Ball; Pedro L Silva; Fernanda F Cruz; Paolo Pelosi; Patricia R M Rocco
Journal:  Br J Anaesth       Date:  2021-06-03       Impact factor: 11.719

Review 9.  Non-invasive Respiratory Support in COVID-19: A Narrative Review.

Authors:  Manel Luján; Javier Sayas; Olga Mediano; Carlos Egea
Journal:  Front Med (Lausanne)       Date:  2022-01-04

10.  Physiotherapy management for COVID-19 in the acute hospital setting and beyond: an update to clinical practice recommendations.

Authors:  Peter Thomas; Claire Baldwin; Lisa Beach; Bernie Bissett; Ianthe Boden; Sherene Magana Cruz; Rik Gosselink; Catherine L Granger; Carol Hodgson; Anne E Holland; Alice Ym Jones; Michelle E Kho; Lisa van der Lee; Rachael Moses; George Ntoumenopoulos; Selina M Parry; Shane Patman
Journal:  J Physiother       Date:  2021-12-23       Impact factor: 7.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.